What is the global market size of Cell Expansion Market?

Cell Expansion Market size was valued at USD 23.02 billion in 2021 and is poised to grow from USD 25.21 billion in 2022 to USD 47.58 billion by 2030, at a CAGR of 9.5% during the forecast period (2023-2030).

Who are the key vendors in the Global Cell Expansion Market?

The global cell expression market is highly competitive and consists of several key players. These players engage in strategies such as collaborations, partnerships, mergers and acquisitions, and product launches to gain a competitive edge. 'Thermo Fisher Scientific Inc. (United States)', 'Merck KGaA (Germany)', 'Lonza Group Ltd. (Switzerland)', 'GE Healthcare (United States)', 'Sartorius AG (Germany)', 'Promega Corporation (United States)', 'Agilent Technologies, Inc. (United States)', 'Bio-Rad Laboratories, Inc. (United States)', 'Eppendorf AG (Germany)', 'Takara Bio Inc. (Japan)', 'GenScript Biotech Corporation (China)', 'CellGenix GmbH (Germany)', 'BD Biosciences (United States)', 'Novasep Holding S.A.S. (France)', 'OriGene Technologies, Inc. (United States)', 'Lonza Biologics Plc (United Kingdom)', 'Danaher Corporation (United States)', 'Wuxi AppTec Co., Ltd. (China)', 'Charles River Laboratories International, Inc. (United States)', 'Miltenyi Biotec GmbH (Germany)', 'New England Biolabs, Inc. (United States)', 'Qiagen N.V. (Netherlands)'

What is the key driver of Global Cell Expansion Market?

The continuous advancements in genetic engineering technologies, such as CRISPR/Cas9, have facilitated the development of high-performing cell lines for protein expression. These technologies enable precise modification of cell genomes to enhance protein production, optimize cellular pathways, and improve product quality. The availability of well-characterized and highly productive cell lines contributes to the growth of the cell expression market.

What is the key market trend for Global Cell Expansion Market?

Researchers and scientists are exploring and developing novel expression systems to overcome the limitations of traditional platforms. For instance, cell-free expression systems, including cell-free protein synthesis (CFPS), are gaining attention due to their ability to produce proteins without the need for intact cells. Additionally, synthetic biology approaches are being employed to engineer cell lines with enhanced expression capabilities and more efficient protein production.

Which region accounted for the largest share in Global Cell Expansion Market?

With a share of 43.1% in 2023, North America had the greatest proportion. Due to increased government funding initiatives that have sped up the development of regenerative medicine and cellular therapy products as well as the production of stem cells, the region will maintain its leadership position over the future years. As a result, there is a demand for cell expansion platforms in this area. For instance, the FDA and the Medical Technology Enterprise Consortium (MTEC) gave the Southwest Research Institute (SwRI) (U.S.) a total of USD 5.3 million in financing. In order to grow cells for the creation of individualized regenerative medicine, the SwRI invested these monies. The revenue generation in this area is increased by such investments.

Top Cell Expansion Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Cell Expansion Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Cell Expansion industry players.

Cell Expansion Market Competitive Landscape

The global cell expression market is highly competitive and consists of several key players. These players engage in strategies such as collaborations, partnerships, mergers and acquisitions, and product launches to gain a competitive edge.

Cell Expansion Market Top Player’s Company Profiles

Thermo Fisher Scientific Inc. (United States)

Merck KGaA (Germany)

Lonza Group Ltd. (Switzerland)

GE Healthcare (United States)

Sartorius AG (Germany)

Promega Corporation (United States)

Agilent Technologies, Inc. (United States)

Bio-Rad Laboratories, Inc. (United States)

Eppendorf AG (Germany)

Takara Bio Inc. (Japan)

GenScript Biotech Corporation (China)

CellGenix GmbH (Germany)

BD Biosciences (United States)

Novasep Holding S.A.S. (France)

OriGene Technologies, Inc. (United States)

Lonza Biologics Plc (United Kingdom)

Danaher Corporation (United States)

Wuxi AppTec Co., Ltd. (China)

Charles River Laboratories International, Inc. (United States)

Miltenyi Biotec GmbH (Germany)

New England Biolabs, Inc. (United States)

Qiagen N.V. (Netherlands)

Cell Expansion Market Recent Development

In March 2024, CellRev, in partnership with Getinge, launched a breakthrough adherent cell expansion platform, Livit ACE. Designed to eliminate many of the limitations and inefficiencies associated with adherent cell culture, Livit ACE reduces costs, enhances productivity and accelerates development times.
In February 2024, Multiply Labs and Thermo Fisher Scientific expanded partnership to automate cell expansion and separation in cell therapy manufacturing.
In September 2023, BioCentriq, Inc. and panCELLa, a Pluristyx Company, signed a research agreement to evaluate the ability of panCELLa's genetically engineered, induced Pluripotent Stem Cell (iPSC)-derived, feeder cells to activate and positively impact the expansion rate, total yield, and potency of manufactured NK cells.
In April 2023, Abbott announced the launch of its new Freestyle Libre 3 continuous glucose monitoring (CGM) system. The Freestyle Libre 3 is a small, wearable sensor that measures blood glucose levels every minute and sends the data to a smartphone app. The system is designed to be more user-friendly and affordable than other CGM systems on the market.
In March 2023, Medtronic announced the launch of its new MiniMed 780G hybrid closed-loop insulin delivery system. The MiniMed 780G system is a combination of an insulin pump and a CGM system that automatically adjusts insulin delivery based on blood glucose levels. The system is designed to help people with type 1 diabetes achieve better glycemic control.

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

Cell Expansion Market size was valued at USD 33.53 Billion in 2024 and is poised to grow from USD 36.98 Billion in 2025 to USD 81.02 Billion by 2033, growing at a CAGR of 10.3% during the forecast period (2026–2033).

The cell expansion industry is characterized by fierce competition, with the rapid adoption of new technologies, cell-based therapies and increasing demand for the biopharmaceuticals by major market players focuses on strategic partnerships, acquisitions and innovation to maintain a competitive edge. This market also has an increasing number of start-ups and emerging companies introducing niche solutions, contributing to the dynamic environment. 'Thermo Fisher Scientific (US)', 'Becton, Dickinson and Company (US) ', 'Lonza Group (Switzerland) ', 'Corning Incorporated (US) ', 'Merck KGaA (Germany) ', 'Sartorius Stedim Biotech SA (Germany) ', 'Terumo Corporation (Japan) ', 'Miltenyi Biotec GmbH (Germany) ', 'Danaher Corporation (US) ', 'Stemcell Technologies Inc. (Canada) ', 'Beckman Coulter Inc. (US) ', 'Takara Bio Inc. (Japan) ', 'RepliCel Life Sciences (Canada) ', 'NexImmune Inc. (US) ', 'Celltainer Biotech BV (Netherlands) ', 'Repligen Corporation (US) ', 'Getinge AB (Sweden) ', 'Bio-Techne Corporation (US) ', 'PromoCell GmbH (Germany) ', 'Himedia Laboratories (India)'

The widespread use of cellular expansion in biopharmaceutical development is another important growth driver. Biopharmaceuticals, such as the monoclonal antibodies, vaccines, and cell-based therapies, rely heavily on complex, scalable cell expansion pathways. The increasing prevalence of chronic diseases and the global demand for personalized medicines has created a need for high-quality biopharmaceuticals.

Application of 3D Cell Culture and Bioreactor Technology: A key component inside the cell expansion market trend is the shift from the traditional secondary cell culture systems to advanced 3D cell culture techniques. 3-dimensional cell cultures accurately mimic the biological environment of cells, enhancing cell function and viability. Technology is increasingly being used in regenerative medicine, cancer research and drug development.

As per cell expansion market outlook, North America currently dominates the cell expansion market, mainly due to its advanced healthcare infrastructure, huge investments in R&D, and presence of leading biotechnology and pharmaceutical companies. North America dominates the global cell expansion market, largely due to its established biotechnology sector, significant R&D investments, and strong focus on regenerative medicine. The region is anticipated to retain its leading position in the coming years due to a rise in the funding initiatives by government agencies, which has accelerated the manufacturing of stem cells and the development of regenerative medicines and cellular therapy products. This, in turn, drives the demand for cell expansion platforms in this region. Asia Pacific is expected to witness the fastest CAGR of over 15.0% during the forecast period, due to increasing initiatives by several local pharmaceutical and biotechnology companies to develop and commercialize their cellular therapies. Countries like China, Japan, and India are witnessing a surge in demand for stem cell therapies and biopharmaceutical production, driven by a growing prevalence of chronic diseases and an aging population. The region's cost-effective manufacturing capabilities and rapidly expanding clinical trial activities make it a global hub for cell-based research and production, contributing to its accelerated growth.

Top Cell Expansion Companies

Cell Expansion Market Competitive Landscape

FAQs

What is the global market size of Cell Expansion Market?

Who are the key vendors in the Cell Expansion Market?

What is the key driver of Cell Expansion Market?

What is the key market trend for Cell Expansion Market?

Which region accounted for the largest share in Cell Expansion Market?

Request Free Customization